Tag: Chief Executive Officer

May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 11, 2018

VanadiumCorp Applauds California, USA for New Solar Requirement

VanadiumCorp Resource Inc. (TSX:VRB) (the "Company") applauds California's new solar requirement as it will foster increased demand for vanadium-based energy...
May 10, 2018

Copper-Gold Explorer Bezant Resources Bets on the Philippines

Bezant Resources has released a strategic review of its copper-gold assets that concludes that its Philippine Mankayan project has “major...
May 10, 2018

Rosetta Stone Inc. Reports First Quarter 2018 Results

Rosetta Stone Inc (NYSE:RST), a world leader in technology based learning solutions announced financial results for the first quarter ended...
May 10, 2018

MicroVision, Inc. Announces New License Agreement with a Leading Technology Company

MicroVision Inc (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology announced that it entered into a license...
May 10, 2018

Prize Mining Samples 2.73 Percent Copper Over 6 Meters at the Manto Negro Oxide Copper Project

Prize Mining has announced additional assay results from the ongoing sampling program on its Manto Negro Copper Project in Coahuila...
May 10, 2018

Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

Precision Therapeutics (NASDAQ:AIPT) a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved...
May 10, 2018

BeiGene Reports First Quarter 2018 Financial Results

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment...